Literature DB >> 15604628

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.

Angela Trepanier1, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle, Lori Ann Correia, Robin Bennett, Barbara Pettersen, Terri Diamond Ferlita, Josephine Wagner Costalas, Katherine Hunt, Susan Donlon, Cecile Skrzynia, Carolyn Farrell, Faith Callif-Daley, Catherine Walsh Vockley.   

Abstract

These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without genetic testing. They were developed by members of the Practice Issues Subcommittee of the National Society of Genetic Counselors Cancer Genetic Counseling Special Interest Group. The information contained in this document is derived from extensive review of the current literature on cancer genetic risk assessment and counseling as well as the personal expertise of genetic counselors specializing in cancer genetics. The recommendations are intended to provide information about the process of genetic counseling and risk assessment for hereditary cancer disorders rather than specific information about individual syndromes. Key components include the intake (medical and family histories), psychosocial assessment (assessment of risk perception), cancer risk assessment (determination and communication of risk), molecular testing for hereditary cancer syndromes (regulations, informed consent, and counseling process), and follow-up considerations. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider's professional judgment based on the clinical circumstances of a client.

Entities:  

Mesh:

Year:  2004        PMID: 15604628     DOI: 10.1023/B:JOGC.0000018821.48330.77

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  87 in total

Review 1.  Risk communication in genetic testing for cancer susceptibility.

Authors:  R T Croyle; C Lerman
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.

Authors:  Y Kitamura; P J Goodfellow; K Shimizu; M Nagahama; K Ito; W Kitagawa; H Akasu; H Takami; S Tanaka; S A Wells
Journal:  Oncogene       Date:  1997-06-26       Impact factor: 9.867

3.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis.

Authors:  J R Howe; S Roth; J C Ringold; R W Summers; H J Järvinen; P Sistonen; I P Tomlinson; R S Houlston; S Bevan; F A Mitros; E M Stone; L A Aaltonen
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

4.  The influence of psychological distress on use of genetic testing for cancer risk.

Authors:  C Lerman; M D Schwartz; T H Lin; C Hughes; S Narod; H T Lynch
Journal:  J Consult Clin Psychol       Date:  1997-06

5.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Authors:  L C Hartmann; T A Sellers; D J Schaid; T S Frank; C L Soderberg; D L Sitta; M H Frost; C S Grant; J H Donohue; J E Woods; S K McDonnell; C W Vockley; A Deffenbaugh; F J Couch; R B Jenkins
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

6.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

7.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 8.  Role of the genetic counselor in familial cancer.

Authors:  J A Peters; J E Stopfer
Journal:  Oncology (Williston Park)       Date:  1996-02       Impact factor: 2.990

9.  Accuracy of family cancer history in breast cancer patients.

Authors:  B Theis; N Boyd; G Lockwood; D Tritchler
Journal:  Eur J Cancer Prev       Date:  1994-07       Impact factor: 2.497

Review 10.  The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

Authors:  N M Lindor; M H Greene
Journal:  J Natl Cancer Inst       Date:  1998-07-15       Impact factor: 13.506

View more
  94 in total

1.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

Review 2.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

3.  Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Authors:  Adam H Buchanan; Santanu K Datta; Celette Sugg Skinner; Gail P Hollowell; Henry F Beresford; Thomas Freeland; Benjamin Rogers; John Boling; P Kelly Marcom; Martha B Adams
Journal:  J Genet Couns       Date:  2015-04-03       Impact factor: 2.537

4.  Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.

Authors:  Rosie O'Shea; Marie Meany; Cliona Carroll; Nuala Cody; David Healy; Andrew Green; Sally Ann Lynch
Journal:  J Genet Couns       Date:  2015-09-26       Impact factor: 2.537

5.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

6.  Predictive testing of eighteen year olds: counseling challenges.

Authors:  Clara L Gaff; Elly Lynch; Lesley Spencer
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

7.  The relationship of nondirectiveness to genetic counseling: report of a workshop at the 2003 NSGC Annual Education Conference.

Authors:  Jon Weil; Kelly Ormond; June Peters; Kathryn Peters; Barbara Bowles Biesecker; Bonnie LeRoy
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

Review 8.  Information processing in the context of genetic risk: implications for genetic-risk communication.

Authors:  Holly Etchegary; Colin Perrier
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.537

Review 9.  Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.

Authors:  Georgios Kallinikas; Helai Habib; Dimitrios Tsimiliotis; Evangelos Koutsokostas; Barna Bokor
Journal:  Int Urol Nephrol       Date:  2017-05-31       Impact factor: 2.370

10.  On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.

Authors:  Beth N Peshkin; Tiffani A Demarco; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.